US Patent Issued to ORION on Jan. 13 for "Use of levodopa, carbidopa and entacapone for treating Parkinson's disease" (Finnish Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,363, issued on Jan. 13, was assigned to ORION Corp. (Espoo, Finland).

"Use of levodopa, carbidopa and entacapone for treating Parkinson's disease" was invented by Juha Rouru (Turku, Finland), Mikko Kuoppamaki (Raisio, Finland), Juha Ellmen (Turku, Finland) and Pekka Mannisto (Helsinki).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a method for the treatment of Parkinson's disease comprising simultaneously or sequentially administering to a patient in need of treatment of Parkinson's disease a dosage form comprising (i) levodopa in an amount ranging from 50 mg to 300 mg, (ii) carbidopa in an amount ranging from 25 mg t...